Publication | Closed Access

The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD

HypertensionRenal FunctionCardiovascular DiseaseMedicineKidney FailureChronic Kidney DiseasePharmacotherapyBiochemical SafetyRenal ProtectionAdding EzetimibeAcute Kidney InjuryPharmacologyNephrology